January 23, 2020 / The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission (EC) has approved the expanded use of STELARA? (ustekinumab) for the treatment of paediatric patie……
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) today announced that the European Commission (EC) has approved a new indication for Revlimid (lenalidomide), in combination with rituximab (anti-……
Roche today announced that the US Food and Drug Administration (FDA) approved Tecentriq? (atezolizumab) in combination with chemotherapy (Abraxane? [paclitaxel protein-bound; nab-paclitaxel] and carboplatin) for the init……
Ono Pharmaceutical Co., Ltd. (Osaka, Japan, President and Representative Director: Gyo Sagara;“ONO”) announced today that it has launched Coralan? (generic name: ivabradine hydrochloride)Tablet 2.5mg, 5mg and 7.5mg (“Cor……
November 22, 2029, Merck, today announced that the European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 28 years of age or older to protect against Ebola ……
Oct. 22, 2029 -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has expanded the label for Fiasp? (insulin aspart injection) 200 u/mL to include use in insulin infusion pumps for the improv……
Copyright Nanjing Dorra Pharmaceutical Technology Co.,Ltd. @ 2018 China All Rights Reserved 苏ICP备12056923号-1